Aspirin‐Free Strategy for Percutaneous Coronary Intervention in Patients With Oral Anticoagulation: Prespecified Subgroup Analysis From the STOPDAPT‐3 Trial

Aspirin‐Free Strategy for Percutaneous Coronary Intervention in Patients With Oral Anticoagulation: Prespecified Subgroup Analysis From the STOPDAPT‐3 Trial

Background The effects of aspirin‐free strategy on bleeding and cardiovascular events in patients undergoing percutaneous coronary intervention with oral anticoagulation (OAC) have not been fully elucidated. Methods and Results We conducted the prespecified subgroup analysis based on the use of OAC,...

Full description

Saved in:
Bibliographic Details
Main Authors: Masahiro Natsuaki, Hirotoshi Watanabe, Takeshi Morimoto, Ko Yamamoto, Yuki Obayashi, Ryusuke Nishikawa, Kenji Ando, Satoru Suwa, Tsuyoshi Isawa, Hiroyuki Takenaka, Tetsuya Ishikawa, Minoru Yamada, Tetsuzo Wakatsuki, Yoichi Nozaki, Hideki Kitahara, Ryuichi Kato, Ryoma Kawai, Yohei Kobayashi, Mitsuru Ishii, Yoshitaka Goto, Koh Ono, Takeshi Kimura
Format: Article
Language:English
Published: Wiley 2024-08-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
aspirin‐free strategy
oral anticoagulation
percutaneous coronary intervention
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.123.034201
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.123.034201

Similar Items